After reading more about aluminum and silicon, I am not as sure that it should be used for AD prevention/treatment.
There is some mention that silicon could precipitate aluminum into aluminosilicates. However, the balance of evidence appears in favor. There is substantial uncertainty about this treatment and as there is minimal commercial interest in developing it this uncertainty is likely to persist. Those pursuing silicon therapy could post urinary aluminum and cognitive scores to forum's wiki. Perhaps the Buck Institute could help out with cognitive testing.
Just to see if anyone is paying attention, I should mention that our loved one with AD has been treated with MPL A.
This news broke almost 2 years ago and there was considerable excitement at the time.http://www.sciencedaily.com/releases/20 ... 143852.htmhttp://www.pnas.org/content/110/5/1941.full
Something that seems to have been overlooked is that MPL A is already available. In fact, girls in many developed
nations have received a few doses of it. Women might receive protection against AD, though they might have to be
caregivers for the men who do not receive the vaccine.
See page 21. Cervarix contains 50 micrograms of MPL A. Unfortunately, it also contains 0.5 mg of AL3+.http://www.gsk.ca/english/docs-pdf/prod ... rvarix.pdf
In the PNAS study mice received weekly doses of 50 micrograms of MPL A.
With Cervarix vaccination, people receive three 50 microgram doses. The vaccine dose of MPL A is much less
than the mice received, though it still might offer some protection.
MPL A is a very well researched vaccine adjuvant and a doctor might be able to obtain it.http://www.enzolifesciences.com/ALX-581 ... dy-to-use/
If anyone finds a supplier for human use, please post the information to the forum.